BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32949706)

  • 1. LncRNA STARD13-AS blocks lung squamous carcinoma cells growth and movement by targeting miR-1248/C3A.
    Li G; Guo X
    Pulm Pharmacol Ther; 2020 Oct; 64():101949. PubMed ID: 32949706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior 
of Lung Squamous Cell Carcinoma H520 Cells].
    Gou L; He Y; Qiu P; Huang B
    Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
    Li H; Zhao Q; Tang Z
    Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H3K27ac-activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR-450b-5p/miR-515-5p/YAP1 axis.
    Ye P; Lv X; Aizemaiti R; Cheng J; Xia P; Di M
    Cell Prolif; 2020 May; 53(5):e12797. PubMed ID: 32297697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
    Ma J; Qi G; Li L
    Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression.
    Zhao Z; Li H; Li J; Rong Y; Zhao L; Hao M; Tian F
    J Cardiothorac Surg; 2024 Apr; 19(1):222. PubMed ID: 38627774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
    Liu L; Li Y; Zhang R; Li C; Xiong J; Wei Y
    BMC Pulm Med; 2020 Jun; 20(1):163. PubMed ID: 32513149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC01089 suppresses lung adenocarcinoma cell proliferation and migration via miR-301b-3p/STARD13 axis.
    Qian Y; Zhang Y; Ji H; Shen Y; Zheng L; Cheng S; Lu X
    BMC Pulm Med; 2021 Jul; 21(1):242. PubMed ID: 34281560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
    Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
    Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13.
    Chen L; Hu W; Li G; Guo Y; Wan Z; Yu J
    Cell Mol Biol Lett; 2019; 24():20. PubMed ID: 30899277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA.
    Hu Z; Liu Y; Tang J; Luo R; Qin J; Mo Z; Xie J; Jiang X; Wei S; Lin C
    Life Sci; 2023 May; 321():121578. PubMed ID: 36958438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.
    Zeng F; You S; Dai X
    Histol Histopathol; 2022 May; 37(5):483-492. PubMed ID: 35098525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression.
    Hu J; Xiang X; Guan W; Lou W; He J; Chen J; Fu Y; Lou G
    J Cardiothorac Surg; 2021 Nov; 16(1):330. PubMed ID: 34772428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
    Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
    PeerJ; 2023; 11():e16447. PubMed ID: 38084139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1.
    Chen C; Tang J; Xu S; Zhang W; Jiang H
    Biomed Res Int; 2020; 2020():2547902. PubMed ID: 32351986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA.
    Ren P; Xing L; Hong X; Chang L; Zhang H
    Cancer Med; 2020 Oct; 9(20):7706-7716. PubMed ID: 32871048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
    Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
    Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.